A study to assess the long-term safety of tazemetostat
- 29 janvier 2025 - 1 mn de lecture
This study will provide continuing availability to tazemetostat for people that have previously completed participation in a tazemetostat study, either with monotherapy (single drug treatment) or combination therapy. The aim of the study will be to assess the long-term safety of tezemetostat.
29 janvier 2025
1 mn de lecture
Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot...
29 janvier 2025
1 mn de lecture
Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis
29 janvier 2025
1 mn de lecture
Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET
29 janvier 2025
1 mn de lecture
Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly
29 janvier 2025
1 mn de lecture
Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg
29 janvier 2025
1 mn de lecture
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients
29 janvier 2025
1 mn de lecture
Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.
29 janvier 2025
1 mn de lecture
Quality of Life in Patients With Inoperable Malignant Bowel Obstruction
29 janvier 2025
1 mn de lecture
Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours
29 janvier 2025
1 mn de lecture